Investor Relations

The current position:Home > Investor Relations >

Board of Directors



Yuying Zhang 

Chairman of the Board and Director

Mr. Zhang has served as the Chief Executive Officer and Chairman of Shineco since 2011. Mr. Zhang was the principal founder of Tenet-Jove, which was established in 1995 with his research and development of Luobuma functional fiber healthcare products. Mr. Zhang has served as the Chairman and CEO of Tenet-Jove since December 2003, under his leadership, the company has worked with more than 20 research institutions and enterprises and has obtained numerous national invention and new product patent rights for Luobuma product development. From 1995 to December 2003, Mr. Zhang served as general manager of Tianjin Balas Technological Development Co., Ltd. Prior to starting Tenet-Jove in 1995, Mr. Zhang was the deputy director at the Army Institute of Integrative Medicine. From 1991 to 1994, Mr. Zhang was the Executive Director and Deputy General Manager at Shan Haidan Pharmaceutical Group, where Mr. Zhang was responsible for strategic development planning and marketing. Mr. Zhang is a senior economist with a degree from China Central Radio and Television University in China. Mr. Zhang has been chosen as director because his knowledge and extensive experience in research and development and management.


Sam Wang


Mr. Wang has served as the Chief Financial Officer since February 2015 and Director since 2016. Mr. Wang has worked for Shineco, Inc. since 2011 where he served as Financial Controller until his appointment as Chief Financial Officer. Prior to joining Shineco, Mr. Wang worked for Citi Bank from 2008 till 2011, where he served as Manager of Corporate Finance. Mr. Wang obtained a Masters in Commerce with a concentration in applied finance from The University of Queensland in 2010. In 2008, he received a bachelor’s degree in Accounting from Griffith University in Australia. Mr. Wang was chosen as a director because of his extensive finance background and his knowledge of the Registrant's business operations.


Jiping Chen


Mr. Chen has been a director for Shineco since 2011. Mr. Chen has served as Chairman of Ankang Longevity Group since 1992. From 1985 to 1992, Mr. Chen worked at Ankang Longevity Group where he a marketing manager. From February 1975 to September 1985, Mr. Chen worked at the Ankang Area Public Bus Company where he served as company staff. From February 1973 to January 1975, he worked for Ankang County. Mr. Chen has been chosen as director because of his experience in the traditional Chinese medicine business and his familiarity with Ankang Longevity Group's operations.


Ying (Teresa) Zhang 

Independent Director

Ms. Zhang has been a director for Shineco since October 2014. Since October 2010, Ms. Zhang has served as a director for Mixbox Co. Ltd., an international chain store management company. From January 2010 through December 2010 Ms. Zhang served as the chief financial officer and the director of Cleantech Solutions International, Inc., a U.S. public company (NASDAQ: CLNT) that manufactures wind power equipment in China. Ms. Zhang was chosen to serve as a member of the board of directors because of her experience with U.S. GAAP, as well as her extensive prior work experience and educational background in the accounting field. Ms. Zhang was previously an auditing manager at GC Alliance HK CPA in Beijing from July 2005 until January 2010, where she provided auditing services to China-based companies. From January 2003 through June 2005,Ms. Zhang served as a liaison officer for the Australian-Chinese Friendship Business Association, a trade organization, and from July 2000 to September 2002 she was an auditor at Ernst & Young in Beijing. None of these companies that Ms. Zhang worked with is related to or affiliated with us. Ms. Zhang is a certified practicing accountant in Australia. Ms. zhang received a bachelor degree in international accounting from Renmin University in China in 1996 and a master's degree in accounting from Macquarie University in Australia in 2005.


Yajun Shi

Independent Director

Mr. Shi has been a director for Shineco since October 2014. Mr. Shi is an associate professor and supervisor of postgraduate education at Shaanxi University of Chinese Medicine, is currently the vice president of the College of Pharmacy of Shaanxi University of Chinese Medicine, and is the director of instrument center and committee member of the Traditional Chinese Medicine Chinese Drugs Pharmaceutics Association. Mr. Shi graduated from Shaanxi University of Chinese Medicine in June 1999, and has been engaging in new medicine developing successively in The Fourth Military Medical University, the Pharmaceutical Research Institute and Shaanxi Tiansen Medicine Development Company. In July 2003, Mr. Shi received Master's Degree from the College of Pharmacy of Shaanxi University of Chinese Medicine. In July 2012, Mr. Shi received Doctor of Medicine degree (M.D.) from Chengdu University of Traditional Chinese Medicine where he specialized in traditional Chinese medicine preparation. Mr. Shi's major research efforts are focused on traditional Chinese medicine and health products, focusing on the basic study and application of a Chinese medicine nasal drug applying system, the study of traditional Chinese medicine powder characterization, and the modification and the adaptability, as well as the research and development of, healthy foods. Mr. Shi has published more than 40 academic papers, and compiled and published six professional books. Mr. Shi was chosen as a director because of his extensive knowledge and research of traditional Chinese medicines.


Leiger Yongmin Yang

Independent Director

Mr. Yang has been a director for Shineco since January 2015. Mr. Yang founded in 2012 China Offshore Financial Group (COFG), a professional offshore financial services provider, focused on financial services for private equity and venture capital firms, outbound and inbound investments, international trading, family trusts, and tax planning. Prior to founding COFG, Mr. Yang served as the General Manager of Offshore Incorporations Limited Group & Vistra Group (OV Group) beginning in 2010. The OV Group focuses on the formation and maintenance of offshore companies, fund formation and fund administration, immigration and trust services. From 2008 to 2010, Mr. Yang was the Vice President of a Chinese venture capital firm, Yellow River Delta Fund, responsible for fundraising and overseeing portfolio companies, with a particular focus on investment and management in the equipment manufacturing industry, modern agriculture and the “cleantech” industry. Mr. Yang has also worked as Chief Editor of the Chinese Asian Venture Capital Journal since 2006, where he is responsible for content of the weekly Chinese Asian Venture Capital Journal. Mr. Yang has spent the major part of his career in the private equity and venture capital sectors. Yang holds a Bachelor of Journalism degree from Jilin University in China. He was chosen as a director because of his hands-on experience in the private equity and venture capital sectors and his strong network with leading venture capital and private equity firms, law firms, accounting firms and banks in China.


Hua Yang

Independent Director

Ms. Yang has been a director for Shineco since XX 2016. Since March 2007, Ms. Yang has served as the Copartner and Lawyer of Grandall Law Firm (Beijing), which is one of the largest trans-regional partnership law firm in China. From July 2001 to February 2007, Ms. Yang has served as the Lawyer of Beijing Weiheng Law Firm. From January 2002 to January 2003, Ms. Yang was the Visiting Lawyer of Canada Fraser Milner Casgrain LLP and Pothier Delisle Law Office. From July 1995 to August 1999, Ms. Yang was a Legal manager with Weihai International Trust and Investment Corporation. She has two master’s degrees in law from Indiana University in the US and Renmin University in China and got a bachelor's degree in Law from Northwest University of Political Science and Law in China. Ms. Yang was chosen as a director because of her experience in corporation law, foreign investment, international litigation and arbitration.

Board Committee Composition


(1) Committee member

(2) Committee chair

(3) Audit committee financial expert